Related by context. Frequent words. (Click for all words.) 59 Phase Ib II 58 phase IIa clinical 57 Phase IIIb 56 Phase III Clinical Trial 56 phase IIb clinical 56 multicenter Phase 56 Phase 2b clinical trials 56 Initiates Phase II 56 Phase 1b trial 56 Phase Ib clinical 56 phase IIa 55 Pivotal Phase III 55 Pivotal Study 55 Patient Enrollment 55 Alzhemed TM 55 Pulmonary Arterial Hypertension 55 phase Ib 55 Completes Enrollment 55 Pain Therapy 54 ABSORB trial 54 Daclizumab 54 phase IIb 54 Pirfenidone 54 Phase 2a clinical 54 RNAi Therapeutics 53 Pivotal Trial 53 IIa trial 53 Mipomersen 53 Pivotal Phase 53 MKC# 53 IMC #B 53 Phase III Trial 53 Phase III 53 forodesine 53 KRN# 53 Phase 2a trial 53 Initiate Phase 53 Tesetaxel 53 IND submission 53 Presents Positive 53 metastatic hormone refractory 53 Fibrillex TM 53 Phase IIB 53 confirmatory Phase III 53 registrational trial 52 Commences Phase 52 Acute Ischemic Stroke 52 confirmatory Phase 3 52 Phase IIb trials 52 Etanercept 52 Phase IIa clinical 52 Cetrorelix 52 placebo controlled Phase 52 Alemtuzumab 52 II Clinical Trial 52 PLK1 SNALP 52 Phase IIa trial 52 Phase 2b clinical 52 Gabapentin GR 52 Phase 1b clinical 52 PEG SN# 51 YOUR LOCAL ANIMAL SHELTER 51 Autoimmune Disease 51 KNS # 51 Post Operative 51 INCB# [001] 51 multicenter clinical 51 Phase III clinical 51 AeroLEF TM 51 Phase 2b trial 51 TACI Ig 51 Metastatic Melanoma 51 BLA submission 51 Epratuzumab 51 Eculizumab 51 Phase 2b study 51 Phase IIa clinical trials 51 post herpetic neuralgia PHN 51 Hypoactive Sexual Desire Disorder 51 Receives Orphan Drug Designation 51 StemEx 51 Phase IIb clinical 51 Phase 2a 50 TOLAMBA 50 pulmonology portfolio 50 ThermoDox R 50 Rheumatoid Arthritis RA 50 double blinded placebo 50 pivotal Phase III 50 placebo controlled clinical 50 GVAX R 50 Investigational Device Exemption IDE 50 Phase Ib 50 Nuvion 50 relapsing multiple sclerosis 50 relapsed refractory multiple myeloma 50 Allovectin 7 R 50 Phase IIb 50 EDEMA4 50 Microplasmin 50 Breast Cancer Treatment